Korean J Psychopharmacol.  2001 Dec;12(4):277-286.

Pharmacological Treatment for Body Dysmorphic Disorder

• Paik KC

Abstract

In spite of the long history of notice, research on the pharmacotherapy of body dysmorphic disorder is limited. No placebo-controlled, continuation, maintenance, or discontinuation studies have been published. But accumulated data and experiences in recent days enable us even roughly to set up a pharmacological treatment step for body dysmorphic disorder. In addition to the clinical aspect of body dysmorphic disorder and its relation to obsessive-compulsive disorder, this article reviewed recent researches and clinical experiences about the pharmacotheray issues like SRI treatment, augmented treatment strategy using buspirone or neuroleptics or others, clomipramine pulse-loaded intravenous therapy, and other treatment methods including ECT and brain surgery, mainly for the purpose of making helpful guidelines for the clinicians. Some tips about cognitive-behavior therapy and future research directions were also added.

Keyword

Body dysmorphic disorder; Pharmacotherapy; Obsessive-compulsive disorder

MeSH Terms

Antipsychotic Agents
Body Dysmorphic Disorders*
Brain
Buspirone
Clomipramine
Drug Therapy
Obsessive-Compulsive Disorder
Antipsychotic Agents
Buspirone
Clomipramine